- 601. receptor structure function
- [ ] (UMLS (CSP) C0599221) =Chemical Viewed Functionally
| - 651. RECOVERY
- [A healing process and/or an outcome implying relative health. The term is typically used in the context of direct and indirect effects of sickness or injury. (NCI) ( NCI )] (UMLS (NCI) C0237820) =Organism Function
|
- 602. Receptor Tyrosine Kinase Gene
- [Tyrosine kinase receptors (TRKs) are a family of genes encoding neurotrophin receptors that include trkA, trkB, and trkC, which are related to development, differentiation, and survival of neural crest-derived neurons and central cholinergic neurons in normal tissue. The genes encoding trkA, trkB, and trkC are designated NTRK1, NTRK2, and NTRK3 and map to chromosomes 1, 9, and 15, respectively. A member of the TRK gene family, trkE, encodes a non-neuronal receptor for nerve growth factor. (from OMIM 600408) ( NCI )] (UMLS (NCI) C1335675) =Gene or Genome ;
| - 652. Recovery Care
- (UMLS (HL7) C1552451) =Intellectual Product ;
=Clinic/Center;
|
- 603. Receptor Tyrosine Kinase-Like Orphan Receptor 1 Gene
- [This gene is thought to play a role in skeletal and cardiac development, but an exact function has yet to be determined. ( NCI )] (UMLS (NCI) C1335633) ROR1;
ROR1 Gene =Gene or Genome ;
| - 653. RecQ Helicase Family Protein
- [RecQ family proteins are 3'-5' DNA helicases. All RecQ family proteins include a domain of approx. 450 amino acids that contains seven highly conserved motifs, including a 'Walker A-box' ATP-binding motif and a DExH box which is a characteristic of this family. These motifs are found in several DNA and RNA helicases. ( NCI )] (UMLS (NCI) C1335669) =Amino Acid, Peptide, or Protein; Enzyme
|
- 604. Receptor Tyrosine Kinase-Like Orphan Receptor 2 Gene
- [This gene plays a role in early chondrocyte formation, cartilage formation and growth plate development. Mutations in the gene are associated with skeletal disorders. ( NCI )] (UMLS (NCI) C1366544) ROR2;
ROR2 Gene =Gene or Genome | - 654. RecQ Protein-Like (DNA Helicase Q1-Like) Gene
- [This gene is involved in DNA unwinding and the promotion of DNA strand annealing. ( NCI )] (UMLS (NCI) C1335609) RECQL;
RECQL Gene =Gene or Genome ;
|
- 605. receptor upregulation
- [A positive regulatory process that increases ligand-receptor interactions. Increase in receptor binding after ligand exposure can result from receptor activation, aggregation, increase in half-life, and/or an increase in gene expression that leads to de novo receptor synthesis. ( MSH )] (UMLS (CSP) C0949479) =Cell Function; Molecular Function
| - 655. RecQ Protein-Like 4 Gene
- [This gene is involved in the initiation of DNA replication and sister-chromatid cohesion. ( NCI )] (UMLS (NCI) C1335607) RECQL4;
RECQL4 Gene;
=Gene or Genome ;
|
- 606. Receptor, Vascular Endothelial Growth Factor
- [There are three signaling VEGF receptors. The VEGF family members PIGF and VEGF-B with exclusive binding capacities to the VEGFR-1 can influence monocyte activation and differentiation. The VEGFR-2 and VEGFR-3 binding VEGF homologues, VEGF-C and VEGF-D, are mitogens for both vascular and lymphatic endothelial cells. The orf virus encoded VEGF-E homologue binds and activates only the VEGFR-2 and thus may be the prototype of a vascular endothelial cell-specific growth factor. Further specific activities of VEGF and its homologues result from receptor-specific signaling and differential expression of ligands or receptors. A naturally occurring soluble form of the VEGFR-1 suggests a regulatory role for this receptor. ( NCI )] (UMLS (NCI) C0148199) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
| - 656. RecQ Protein-Like 5
- [A member of RecQ helicase family. Northern blot analysis detected RECQL5 expression in almost all tissues tested, with notably strong expression in pancreas and testis. ( NCI )] (UMLS (NCI) C1335670) RecQL5;
=Amino Acid, Peptide, or Protein; Enzyme |
- 607. Receptor-Interacting Protein
- [A 74 kDa serine/threonine kinase originally identified by its ability to associate with Fas/APO-1 and induce cell death. RIP interacts with the cytoplasmic domain of FAS, and with TNFR1 through the adaptor proteins TRADD and TRAFs 1, 2, and 3. ( NCI )] (UMLS (NCI) C0297981) =Amino Acid, Peptide, or Protein; Enzyme
| - 657. RecQ Protein-Like 5 Gene
- [This gene plays a role in the regulation of DNA topology. ( NCI )] (UMLS (NCI) C1335608) RECQL5;
RECQL5 Gene;
=Gene or Genome ;
|
- 608. Receptor-Interacting Serine-Threonine Kinase 2 Gene
- [This gene is involved in apoptosis, signal transduction and the immune response. ( NCI )] (UMLS (NCI) C1335624) RIPK2;
RIPK2 Gene =Gene or Genome ;
| - 658. RECQL
- [RecQL protein is a 13,3 kD peptide (1208 aa), belongs to the RecQ subfamily of helicases and contains from aa 476 to 824 an helicase domain with a potential ATP binding site from aa 502 to 509, and the DEAH box from aa 605 to 608. The expression of RecQ4 gene is partially upregulated in the G1/S phase of cell cycle. It suppresses promiscuous genetic recombination and ensures accurate chromosome segregation. ( NCI )] (UMLS (NCI) C1506962) RecQL Helicase;
=Amino Acid, Peptide, or Protein; Enzyme |
- 609. Receptor-Interacting Serine-Threonine Kinase 3 Gene
- [This gene plays a role in signal transduction and the activation of apoptosis. ( NCI )] (UMLS (NCI) C1335625) RIPK3;
RIPK3 Gene =Gene or Genome ;
| - 659. recreation
- [activity engaged in for pleasure, diversion, amusement or stimulation. ( CSP )] (UMLS (CSP) C0034872) =Daily or Recreational Activity =leisure;
|
- 610. Recession of chamber angle of eye
- [ ] (UMLS (ICD9CM) C0154937) =Pathologic Function ;
| - 660. Recreation Therapist
- [A recreation therapist uses recreational activities for intervention in some physical, social or emotional behavior to bring about a desired change in that behavior and promote the growth and development of the patient.Source: Joel A. DeLisa and Bruce M. Gans, Rehabilitation Medicine: Principles and Practice Second Edition, J.B. Lippincott Company, Philadelphia: 1993, p. 7 ( HL7V3.0 )] (UMLS (HL7) C1552310) =Intellectual Product =Respiratory, Rehabilitative and Restorative Service Providers;
|
- 611. Recession of tendon
- [ ] (UMLS (ICD9CM) C0185466) =Therapeutic or Preventive Procedure
| - 661. Recreation therapy
- (UMLS (ICD9CM) C0034873) =Therapeutic or Preventive Procedure
|
- 612. Reciprocal Translocation
- (UMLS (NCI) C0333714) =Cell or Molecular Dysfunction ;
| - 662. Recreational Drug Use Code
- (UMLS (HL7) C1547812) =Daily or Recreational Activity =HL7 Vocabulary Version 2.5;
=Alcohol;
Tobacco - chewed;
Kava;
Marijuana;
Other;
Tobacco - smoked;
Unknown;
|
- 613. RECLOSE POST OP DISRUPT
- (UMLS (ICD9CM) C0198546) =Therapeutic or Preventive Procedure
| - 663. Rectal
- [By or having to do with the rectum. The rectum is the last 6 inches of the large intestine and ends at the anus. ( NCI )] (UMLS (NCI) C0205052) =Spatial Concept ;
=Body Part;
|
- 614. Recombinant Antibodies
- [Antibodies produced by recombinant DNA techniques. ( NCI )] (UMLS (NCI) C1335676) Recombinant Antibody;
=Amino Acid, Peptide, or Protein; Immunologic Factor | - 664. RECTAL & ANAL STENOSIS
- [ ] (UMLS (ICD9CM) C0156183) =Disease or Syndrome; Anatomical Abnormality
|
- 615. Recombinant Fowlpox Tyrosinase
- [A recombinant fowlpox virus vaccine with potential antineoplastic activity. Binding to the melanoma antigen tyrosinase, recombinant fowlpox-tyrosinase vaccine generates cellular immune responses against melanoma cells expressing the tyrosinase antigen; this effect is enhanced by the co-administration of interleukin 2 (IL-2). Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. ( NCI )] (UMLS (NCI) C1327884) Recombinant Fowlpox-Tyrosinase Vaccine;
rF-TYR;
rF-TYR vaccine;
Tyrosinase-Fowl Pox =Pharmacologic Substance; Immunologic Factor | - 665. RECTAL & ANAL ULCER
- (UMLS (ICD9CM) C0400832) =Disease or Syndrome ;
|
- 616. Recombinant Fowlpox-B7.1
- [A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the stimulatory molecule transgene B7-1. Recombinant fowlpox-B7.1 vaccine may enhance antigen presentation and activate antitumoral cytotoxic T-cells. (NCI04) ( NCI )] (UMLS (NCI) C1134569) Recombinant Fowlpox-B7.1 Vaccine;
rF-B7.1;
rF-B7.1 Vaccine =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 666. Rectal bleeding
- [Discharge of blood from the anus. — 2003(NCI)] (UMLS (ICPC) C0267596) (Rectal bleeding; UZKI ODOLJARIOA; Blodning fra endetarm; Rectaal bloedverlies; VERENVUOTO PERASUOLESTA; Saignement rectal; rektale Blutung; demem rektali; verzes a vegbelbol; Sanguinamento rettale; REKTAL BLODNING; Hemorragia rectal; Hemorragia rectal; BLODNING FRAN ANDTARMEN) =Pathologic Function ;
=Body System, Gastrointestinal; Symptoms and Complaints Component |
- 617. Recombinant Fowlpox-TRICOM
- [A vaccine comprised of a recombinant fowlpox virus vector encoding a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM), which may enhance antigen presentation and activate cytotoxic T-cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. (NCI04) ( NCI )] (UMLS (NCI) C1134570) Recombinant Fowlpox-TRICOM Vaccine;
rF-TRICOM (B7.1.iCAM1-LFA3-Fowlpox);
=Pharmacologic Substance; Immunologic Factor ;
| - 667. Rectal Cancer, Recurrent
- [The reemergence of rectal cancer after a period of remission ( NCI )] (UMLS (NCI) C0278554) =Neoplastic Process
|
- 618. Recombinant Human Growth Hormone
- [A recombinant form of endogenous human growth hormone (GH), a polypeptide produced by the anterior lobe of the human pituitary gland. GH exhibits growth-promoting effects and metabolic effects on carbohydrate, fat, protein and bone metabolism. GH stimulates protein synthesis and the uptake of amino acids into cells, and induces lipolysis in adipose tissues. The secretion of GH increases with sexual maturation and then declines steadily. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=456264&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=456264&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C837" NCI Thesaurus) ( PDQ )] (UMLS (NCI) C0384570) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
| - 668. Rectal foam
- (UMLS (HL7) C0993160) =Biomedical or Dental Material ;
=Foam;
|
- 619. recombinant peptide
- [ ] (UMLS (CSP) C0599286) =Amino Acid, Peptide, or Protein
| - 669. RECTAL MASSAGE
- [ ] (UMLS (ICD9CM) C0193268) =Therapeutic or Preventive Procedure
|
- 620. Recombinant Protein
- [peptides or proteins produced by genes which have been artificially inserted into living cells or cell-free expression systems; index with or without RECOMBINANT DNA and the following RTs as needed. ( CSP )] (UMLS (NCI) C0034861) =Amino Acid, Peptide, or Protein ;
=gene product;
genetic manipulation =Interferon Type I, Recombinant;
125-L-Serine-2-133-interleukin 2;
HBW 023;
reteplase;
Erythrocyte Colony Stimulating Factor;
Somatotropic Hormone;
Colony-Stimulating Factors, Recombinant;
Adipogenesis Inhibitory Factor;
dornase alfa | - 670. RECTAL PACKING
- (UMLS (ICD9CM) C0193147) =Therapeutic or Preventive Procedure
|
- 621. Recombinant Soluble T4
- [A recombinant form of CD4 antigen with anti-HIV application. Recombinant soluble T4 antigen (rsT4) is derived from cell surface antigen CD4 lacking its transmembrane and cytoplasmic domains, thereby is mobile within tissues. rsT4 binds to the envelope glycoprotein gp110 of HIV and prevents the binding of virus to CD4 positive lymphocytes, resulting in an inhibition of virus infectivity. ( NCI )] (UMLS (NCI) C0210233) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 671. rectal prolapse
- [Protrusion of the rectal mucous membrane through the anus. There are various degrees: incomplete with no displacement of the anal sphincter muscle; complete with displacement of the anal sphincter muscle; complete with no displacement of the anal sphincter muscle but with herniation of the bowel; and internal complete with rectosigmoid or upper rectum intussusception into the lower rectum. ( MSH )] (UMLS (CSP) C0034888) =Disease or Syndrome =Procidentia;
Rectal Diseases |
- 622. Recombinant Vaccina-MUC-1 Vaccine
- [A vaccine containing a recombinant vaccinia virus that encodes the gene for human mucin-1, a tumor-associated antigen. Upon administration, recombinant vaccinia-MUC-1 vaccine may elicit a MUC-1-specific cytotoxic T cell response against tumor cells bearing MUC-1. ( NCI )] (UMLS (NCI) C1328072) Recombinant Vaccinia MUC-1;
rV-MUC-1 Vaccine =Pharmacologic Substance; Immunologic Factor ;
| - 672. Rectal Rhabdomyosarcoma
- [A malignant mesenchymal tumor with skeletal muscle differentiation affecting the rectum. ( NCI )] (UMLS (NCI) C1335687) Rhabdomyosarcoma of Rectum;
Rhabdomyosarcoma of the Rectum =Neoplastic Process ;
|
- 623. Recombinant Vaccinia DF3/MUC1 Vaccine
- [A vaccinia virus based vaccine expressing human tumor associated epithelial mucin (DF3 antigen; MUC1). MUC1 antigen, an membrane bound glycoprotein expressed by most glandular and ductal epithelial cells, is overexpressed in various tumors such as, breast, prostate and ovarian cancers. This vaccine could be used in development of immunotherapeutics against cancers expressing MUC1. ( NCI )] (UMLS (NCI) C0796497) rV-DF3/MUC1;
=Pharmacologic Substance; Immunologic Factor | - 673. Rectal Sarcoma
- (UMLS (NCI) C1335688) Sarcoma of Rectum;
Sarcoma of the Rectum =Neoplastic Process ;
|
- 624. recombinant vaccinia virus
- [does not occur in nature, propagated in the laboratory for use as an active vaccine against smallpox; possibly a derivative or recombinant of cowpox or smallpox viruses; used experimentally as a vector for genes expressing foreign protein antigens. ( CSP )] (UMLS (CSP) C0042216) =Virus =pox virus;
recombinant virus | - 674. Rectal Sarcomatoid Carcinoma
- (UMLS (NCI) C1335689) Sarcomatoid Carcinoma of Rectum;
Sarcomatoid Carcinoma of the Rectum =Neoplastic Process ;
|
- 625. Recombinant Vaccinia-B7.1
- [A recombinant vaccinia virus encoding the T-cell co-stimulatory molecule B7-1. Co-administration of recombinant vaccinia-B7.1 and a tumor-associated antigen vaccine may enhance tumor-associated antigen-specific T-cell responses. (NCI04) ( NCI )] (UMLS (NCI) C0879372) Recombinant Vaccinia-B7.1 Vaccine;
rV-B7 (Recomb Vaccinia/B7);
rV-B7.1;
rV-B7.1 Vaccine =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 675. Rectal Signet Ring Cell Adenocarcinoma
- (UMLS (NCI) C0279654) =Neoplastic Process
|
- 626. Recombinant Vaccinia-CEA(6D)-TRICOM
- [A vaccine consisting of recombinant vaccinia virus encoding the tumor-associated antigen carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1, and LFA-3; also called TRICOM). Vaccination with recombinant vaccinia-CEA(6D)-TRICOM vaccine stimulates the host immune system to mount a T-cell response against tumor cells expressing the CEA antigen. The use of TRICOM in the vaccine may elicit a greater antitumor cytotoxic T lymphocyte (CTL) immune response compared to the use of vaccinia-CEA alone. ( NCI )] (UMLS (NCI) C0935789) rV-CEA(6D)/TRICOM;
Vaccinia-CEA-TRICOM Vaccine =Pharmacologic Substance; Immunologic Factor ;
| - 676. Rectal Squamous Carcinoma
- (UMLS (NCI) C1335690) Rectal Squamous Cell Carcinoma;
Squamous Carcinoma of Rectum;
Squamous Carcinoma of the Rectum;
Squamous Cell Carcinoma of Rectum;
Squamous Cell Carcinoma of the Rectum;
=Neoplastic Process ;
|
- 627. Recombinant Vaccinia-GM-CSF
- [A recombinant vaccinia virus that encodes granulocyte-macrophage colony stimulating factor (GM-CSF). By activating T-cells and macrophages, vaccination with recombinant vaccinia GM-CSF may enhance the host immune system response to poorly immunogenic tumors, resulting in decreased tumor growth. (NCI04) ( NCI )] (UMLS (NCI) C1134639) rV GM-CSF;
Vaccinia-GM-CSF Vaccine;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 677. Rectal Tubulovillous Adenoma
- (UMLS (NCI) C1335691) Rectal Villotubular Adenoma;
Tubulovillous Adenoma of Rectum;
Tubulovillous Adenoma of the Rectum;
Villotubular Adenoma of Rectum;
Villotubular Adenoma of the Rectum;
=Neoplastic Process |
- 628. Recombinant Vaccinia-TRICOM Vaccine
- [A vaccine consisting of recombinant vaccinia virus encoding a triad of costimulatory molecules (B7-1, ICAM-1, and LFA-3; also called TRICOM). Vaccination with recombinant vaccinia-TRICOM vaccine stimulates the host immune system to mount a non-specific T-cell response. With the addition of a tumor-associated antigen peptide, this vaccine may enhance a tumor-specific immune response. ( NCI )] (UMLS (NCI) C1099097) rV-TRICOM;
Vaccinia-TRICOM =Pharmacologic Substance; Immunologic Factor ;
| - 678. Rectal Villous Adenoma
- (UMLS (NCI) C0730199) Villous Adenoma of Rectum;
Villous Adenoma of the Rectum;
=Neoplastic Process |
- 629. Recombinant Vaccinia-Tyrosinase
- [A recombinant vaccinia virus (based on the modified vaccinia virus Ankara) expressing tyrosinase. Tyrosinase is a melanoma-specific differentiation agent that catalyzes the synthesis of the melanin precursor dihydroxyphenylalanine (DOPA). Vaccination with this agent may evoke a melanoma-specific T-cell response. ( NCI )] (UMLS (NCI) C0796657) Recombinant Vaccinia-Tyrosinase Vaccine;
rV-TYR;
rV-TYR Vaccine;
Vaccinia-Tyrosinase Vaccine;
VACTYROS =Pharmacologic Substance; Immunologic Factor ;
| - 679. Rectal/anal pain
- (UMLS (ICPC) C0497174) (Rectal/anal pain; UZKI/IPURT-HESTEKO MINA; Smerter i endetarm anus; Pijn anus/rectum; PERASUOLEN/PERAAUKON KIPU; Douleur anale/rectale; rektaler/analer Schmerz; keev xalxolet; vegbel/anus fajdalom; Dolore rettale/anale; ENDETARM/ANAL/REKTAL SMERTE; Dor anal/rectal; Dolor anal/rectal; SMARTA I ANDTARM/ANUS) =Sign or Symptom ;
=Body System, Gastrointestinal; Symptoms and Complaints Component |
- 630. Recombinant Viral Vaccine
- [A vaccine produced from genetically engineered viral vector by introduction of foreign genetic materials to activate immune response in a host. ( NCI )] (UMLS (NCI) C0281606) =Pharmacologic Substance; Immunologic Factor
| - 680. RectalRoute
- [Rectal ( HL7V3.0 )] (UMLS (HL7) C0205536) =Functional Concept =RouteBySite;
=Instillation, rectal;
Enema, rectal;
Enema, rectal retention;
Insertion, rectal;
Topical application, rectal;
Irrigation, rectal |
- 631. recombinant virus
- [virus into which recombinant nucleic acid has been introduced, or whose genome has been modified in vitro by recombinant nucleic acid techniques; also index specific virus. ( CSP )] (UMLS (CSP) C0597363) =Virus ;
=genetic manipulation;
=recombinant vaccinia virus | - 681. RECTANGLE
- [A parallelogram with four right angles. A square is a special rectangle with four equal sides. ( NCI )] (UMLS (NCI) C0205142) =Spatial Concept
|
- 632. recombinase
- [ubiquitous class of enzymes which catalyze DNA strand recombination in bacteria, yeast, Drosophila, immunoglobulin and T cell receptor gene rearrangement, and other systems. ( CSP )] (UMLS (CSP) C0073020) =Amino Acid, Peptide, or Protein; Enzyme ;
=EC 2.7.7;
| - 682. Recto-Vesical Pouch
- (UMLS (NCI) C0230301) =Body Space or Junction
|
- 633. recommendation
- [A non-mandated intent to perform an act where a level of professional responsibility is being accepted by making the proposal. ( HL7V3.0 )] (UMLS (HL7) C0034866) =Idea or Concept =ActMood;
| - 683. rectocele
- [A hernial protrusion of part of the rectum into the vagina. (Dorland, 28th ed) ( MSH )] (UMLS (CSP) C0149771) =Acquired Abnormality =Rectal Diseases;
|
- 634. Reconstituted Whole Blood
- (UMLS (HL7) C1547256) =Intellectual Product =Blood Product Code;
| - 684. RECTOCELE REPAIR
- [ ] (UMLS (ICD9CM) C0677487) =Therapeutic or Preventive Procedure ;
|
- 635. Reconstruction
- [Surgery that is done to reshape or rebuild (reconstruct) a part of the body changed by previous surgery. ( NCI )] (UMLS (NCI) C0524865) =Therapeutic or Preventive Procedure ;
| - 685. Rectoid
- (UMLS (NCI) C0699400) =Steroid; Pharmacologic Substance; Hormone
|
- 636. Reconstruction of eyelid with flaps or grafts
- [ ] (UMLS (ICD9CM) C0176156) =Therapeutic or Preventive Procedure
| - 686. RECTORECTOSTOMY
- (UMLS (ICD9CM) C0193171) =Therapeutic or Preventive Procedure
|
- 637. Reconstruction of muscle and tendon
- [ ] (UMLS (ICD9CM) C0177631) =Therapeutic or Preventive Procedure
| - 687. Rectosigmoid Cancer
- [A colorectal carcinoma involving the rectosigmoid area. The majority are adenocarcinomas. About 50% of colorectal carcinomas occur in the rectosigmoid area. —2002 ( NCI )] (UMLS (NCI) C1327709) Rectosigmoid Carcinoma =Neoplastic Process ;
|
- 638. RECONSTRUCTION OF PENIS
- [ ] (UMLS (ICD9CM) C1261298) =Therapeutic or Preventive Procedure
| - 688. Rectosigmoid Cancer, Recurrent
- [The reemergence of rectosigmoid cancer after a period of remission. ( NCI )] (UMLS (NCI) C0854779) Recurrent Rectosigmoid Cancer;
Recurrent Rectosigmoid Carcinoma;
Relapsed Rectosigmoid Cancer;
=Neoplastic Process |
- 639. Reconstruction of thumb
- [ ] (UMLS (ICD9CM) C0177601) =Therapeutic or Preventive Procedure
| - 689. rectosigmoid growth
- [ ] (UMLS (CSP) C0599287) =Neoplastic Process
|
- 640. Reconstruction of trachea and construction of artificial larynx
- [ ] (UMLS (ICD9CM) C0176491) =Therapeutic or Preventive Procedure
| - 690. Rectosigmoidectomy
- [Surgical removal part or all of the sigmoid colon, and part or all of the rectum. ( NCI )] (UMLS (NCI) C0193063) =Therapeutic or Preventive Procedure
|
- 641. Reconstructive operations on middle ear
- [ ] (UMLS (ICD9CM) C0161868) =Therapeutic or Preventive Procedure
| - 691. rectum growth
- [ ] (UMLS (CSP) C0684200) =Neoplastic Process ;
|
- 642. Record
- [Anything (e.g., a document) providing permanent evidence of or information about past events. ( NCI )] (UMLS (NCI) C0034869) =Intellectual Product
| - 692. rectum obstruction
- (UMLS (NCI) C1406054) Rectum Obstruction Adverse Event;
=Finding ;
|
- 643. Record coming over is a correction and thus replaces a final result
- (UMLS (HL7) C1548155) =Idea or Concept =Observation result status codes interpretation;
| - 693. rectum/anus
- [rectum is the distal segment of the large intestine, between the sigmoid colon and the anus, which is terminal segment of the large intestine, ending at the opening. ( CSP )] (UMLS (CSP) C0178825) =Body Part, Organ, or Organ Component ;
=Bowel, Large;
|
- 644. Record coming over is a correction and thus replaces a final status
- (UMLS (HL7) C1548994) =Idea or Concept =BP Observation Status Codes Interpretation;
| - 694. Rectus Abdominis
- [A long flat muscle that extends along the whole length of both sides of the abdomen. It flexes the vertebral column, particularly the lumbar portion; it also tenses the anterior abdominal wall and assists in compressing the abdominal contents. It is frequently the site of hematomas. In reconstructive surgery it is often used for the creation of myocutaneous flaps. (From Gray's Anatomy, 30th American ed, p491) ( MSH )] (UMLS (NCI) C0206066) =Body Part, Organ, or Organ Component
|
- 645. record target
- [The record target indicates whose medical record holds the documentation of this act. This is especially important when the subject of a service is not the patient himself. ( HL7V3.0 )] (UMLS (HL7) C1550503) =Idea or Concept =indirect target;
| - 695. Rectus Femoris
- (UMLS (NCI) C0584894) =Body Part, Organ, or Organ Component
|
- 646. Record-level event code
- (UMLS (HL7) C1547598) =Intellectual Product =HL7 Vocabulary Version 2.5;
=Reactivate deactivated record;
Add record to master file;
Deactivate: discontinue using record in master file, but do not delete from database;
Delete record from master file;
Update record for master file | - 696. recur
- [To occur again. ( NCI )] (UMLS (NCI) C0034897) =Phenomenon or Process =Pathologic Process;
Disease Attributes =neoplasm/cancer relapse/recurrence |
- 647. Records
- (UMLS (HL7) C1548330) =Idea or Concept =Quantity limited request;
| - 697. RECUR BIL FEM HERN-GANG
- [ ] (UMLS (ICD9CM) C0156118) =Disease or Syndrome ;
|
- 648. Records
- [Used where number of records or instances of items in the query response result set has limitations. ( HL7V3.0 )] (UMLS (HL7) C1553414) =Qualitative Concept =QueryQuantityUnit;
| - 698. RECUR BIL ING HERN-GANG
- [ ] (UMLS (ICD9CM) C0156103) =Disease or Syndrome ;
|
- 649. Recovering
- (UMLS (HL7) C1546959) =Idea or Concept =Patient Outcome;
| - 699. RECUR BIL ING HERN-OBSTR
- (UMLS (ICD9CM) C0554121) =Acquired Abnormality; Disease or Syndrome
|
- 650. recovery
- [Retroactive adjustment such as fee rate adjustment due to contract negotiations. ( HL7V3.0 )] (UMLS (HL7) C1555688) =Idea or Concept =ActInvoiceAdjudicationPaymentGroupCode;
| - 700. RECUR BILAT FEMORAL HERN
- [ ] (UMLS (ICD9CM) C0156144) =Acquired Abnormality; Disease or Syndrome
|
home
